Advanced Oncotherapy plc (LON:AVO – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1.75 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares changing hands.
Advanced Oncotherapy Trading Down 9.1 %
The firm has a 50-day moving average of GBX 1.75 and a 200 day moving average of GBX 1.75. The company has a market cap of £9.49 million, a P/E ratio of -25.00 and a beta of 0.06. The company has a current ratio of 1.26, a quick ratio of 0.13 and a debt-to-equity ratio of 98.71.
About Advanced Oncotherapy
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Recommended Stories
- Five stocks we like better than Advanced Oncotherapy
- What is a Dividend King?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Earnings Per Share Calculator: How to Calculate EPS
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.